Contribution of the Spanish Agency for Medicines and Healthcare Products to the European Committee for the Evaluation of Medicinal Products for Human Use

Autor: Alonso-Gutiérrez, A., Díaz-Ramos, P., Sulleiro-Avendaño, E., de Miguel-Marañón, M., Padilla-Gallego, M.E., Sancho-López, A., Ruiz-Antúnez, S., Prieto-Yerro, C.

Publikováno v: In Revista Clínica Española (English Edition) May 2015 215(4):230-235

Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Autor: de Wit M; Department of Medical Humanities, Amsterdam University Medical Centre, Amsterdam, The Netherlands., Cooper C; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK.; NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK.; WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging, Liège, Belgium., Tugwell P; Department of Medicine, University of Ottawa, Ottawa, Canada., Bere N; Public Engagement Department, European Medicines Agency, 30 Churchill Place, Canary Wharf, London, E14 5EU, UK., Kirwan J; Emeritus Professor of Rheumatic Diseases, University of Bristol, Bristol, UK., Conaghan PG; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.; NIHR Leeds Biomedical Research Centre, Leeds, UK., Roberts C; International Consortium for Health Outcomes Measurement, Hamilton House, 4 Mabledon Place, Bloomsbury, London, WC1H 9BB, UK., Aujoulat I; Université Catholique de Louvain, Institute of Health & Society, Brussels, Belgium., Al-Daghri N; Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia., Araujo de Carvalho I; Department of Ageing and Life Course, World Health Organization, 20 Avenue Appia, 1211, Geneva 27, Switzerland., Barker M; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK., Bedlington N; European Patients' Forum, Chaussée d'Etterbeek 180, Etterbeek, 1040, Brussels, Belgium., Brandi ML; Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.; Fondazione F.I.R.M.O., Florence, Italy., Bruyère O; WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging, Liège, Belgium.; Department of Public Health, Epidemiology and Health Economics, University of Liège, CHU Sart Tilman B23, 4000, Liège, Belgium., Burlet N; WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging, Liège, Belgium., Halbout P; International Osteoporosis Foundation, 9 Rue Juste-Olivier, 1260, Nyon, Switzerland., Hiligsmann M; Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands., Jiwa F; Osteoporosis Canada, Toronto, ON, Canada., Kanis JA; Mary McKillop Health Institute, Australian Catholic University, Melbourne, Australia.; Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK., Laslop A; Scientific Office, Federal Office for Safety in Health Care, Austrian Agency for Health and Food Safety, Vienna, Austria., Lawrence W; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Pinto D; Department of Physical Therapy, College of Health Sciences, Marquette University, Milwaukee, USA.; Center for Healthcare Studies, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Prieto Yerro C; Spanish Agency for Drugs and Medical Devices, Calle Campezo 1, Building 8, 28022, Madrid, Spain., Rabenda V; Department of Public Health, Epidemiology and Health Economics, University of Liège, CHU Sart Tilman B23, 4000, Liège, Belgium., Rizzoli R; WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging, Liège, Belgium.; Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland., Scholte-Voshaar M; Department of Psychology, Health and Technology, University of Twente, Enschede, The Netherlands., Vlaskovska M; Medical Faculty, Department of Pharmacology, Medical University Sofia, 2, Zdrave Str, 1431, Sofia, Bulgaria., Reginster JY; WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging, Liège, Belgium. jyreginster@uliege.be.; Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia. jyreginster@uliege.be.; Department of Public Health, Epidemiology and Health Economics, University of Liège, CHU Sart Tilman B23, 4000, Liège, Belgium. jyreginster@uliege.be.

Publikováno v: Aging clinical and experimental research [Aging Clin Exp Res] 2019 Jul; Vol. 31 (7), pp. 905-915. Date of Electronic Publication: 2019 Apr 16.

Linaclotide for treatment of irritable bowel syndrome--the view of European regulators.

Autor: Berntgen M; European Medicines Agency, London, United Kingdom. Electronic address: michael.berntgen@ema.europa.eu., Enzmann H, Schabel E, Prieto Yerro C, Gómez-Outes A, Salmonson T, Musaus J

Publikováno v: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2013 Sep; Vol. 45 (9), pp. 724-6. Date of Electronic Publication: 2013 May 21.

[Changes in the pattern of use of non-conventional amphotericin B after the implementation of a training intervention at the San Carlos Clinical Hospital of Madrid].

Autor: Prieto Yerro C; Servicio de Farmacología Clínica Hospital Clínico San Carlos C/Doctor Martín Lagos, s/n 28040 Madrid. conchapy@hotmail.com, Laredo Velasco L, Rodríguez Bernardino A, Vargas Castrillón E, Ambit Avila I, Merchante Medina A

Publikováno v: Revista espanola de salud publica [Rev Esp Salud Publica] 2001 Jul-Aug; Vol. 75 (4), pp. 353-60.

Prophylaxis of venous thromboembolism in non-surgical patients,Profilaxis del tromboembolismo venoso en pacientes no quirúrgićos

Autor: Moreno González, A., Prieto Yerro, C., Emilio Vargas-Castrillón, Laredo Velasco, L., Asenjo Correa, S.

Publikováno v: Scopus-Elsevier

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c4b35e9998966efc36fea24e6f4dd1e6
http://www.scopus.com/inward/record.url?eid=2-s2.0-0036077649&partnerID=MN8TOARS